eXp Realty Exceeds 1,000-Agent Milestone in South Africa

eXp Realty Exceeds 1,000-Agent Milestone in South Africa BELLINGHAM, Wash., Aug. 10, 2023 (GLOBE NEWSWIRE) — eXp Realty®, “the most agent-centric real estate brokerage on the planet™” and the core subsidiary of eXp World Holdings, Inc. (Nasdaq: EXPI), today announced it has exceeded 1,000 agents across South Africa, representing an over 74% increase from the […]

Duck Creek Technologies Expands to the Indian Market, Offering Its Global Core Technology Platform to India-Based Insurance Carriers

The company’s Indian subsidiary signs its first full-suite customer partnership in the region with HDFC ERGO Mumbai, Aug. 09, 2023 (GLOBE NEWSWIRE) — Duck Creek Technologies India LLP, a subsidiary of Duck Creek Technologies, today announced a historical milestone with its expansion into the Indian general insurance market. Duck Creek Technologies India LLP now offers […]

جامعة محمد بن زايد للذكاء الاصطناعي تطلق برامج في علم الروبوتات وعلوم الحاسوب

تلبية للطلب المتزايد على هذه التخصصات على مستوى العالم أبوظبي، الإمارات العربية المتحدة، 3 أغسطس 2023: أطلقت جامعة محمد بن زايد للذكاء الاصطناعي قسمين جديدين يشملان مجالي علم الروبوتات وعلوم الحاسوب، وذلك تلبية للطلب العالمي المتزايد على هذين التخصصين، إذ من المتوقع أن يصل الطلب إلى 225 مليار دولار[i]  في مجال علم الروبوتات و 140 […]

Abu Dhabi’s artificial intelligence university establishes dedicated robotics and computer science departments to meet surging global demand

ABU DHABI, United Arab Emirates, Aug. 03, 2023 (GLOBE NEWSWIRE) — Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) has established two new departments and four associated graduate programs dedicated to robotics and computer science, catering to the surging global demand for these disciplines, which is expected to hit USD $225 billioni and $140 billion, respectively, […]

Zenas BioPharma annonce la publication d’une étude de phase 2 sur l’obéxélimab, un traitement expérimental pour la maladie liée aux IgG4 (ML-IgG4), dans The Lancet Rheumatology

L’étude a montré que l’obéxélimab produisait une amélioration clinique rapide, forte et soutenue, y compris une rémission clinique complète, chez la plupart des patients atteints de ML-IgG4 active Les résultats soutiennent la poursuite du développement de l’obéxélimab pour le traitement de la ML-IgG4 et potentiellement d’autres maladies auto-immunes à médiation par les cellules B WALTHAM, […]

EMAIL NEWSLETTER

Subscribe to receive inspiration, ideas, and news in your inbox